Medical Hemostat
The Surgical Hemostat Market Comparison and New Hemostat Technology Blog
Friday, May 29, 2009
TSX Delisting Review - Haemacure Corporation (HAE)
TSX is reviewing the common shares of the Company with respect to meeting the continued listing requirements. The Company has been granted 150 days in which to regain compliance with these requirements, pursuant to the Remedial Review Process.
‹
›
Home
View web version